z-logo
open-access-imgOpen Access
Immune checkpoint inhibitors may be safe for patients with preexisting autoimmune disease
Author(s) -
Fillon Mike
Publication year - 2019
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/caac.21587
Subject(s) - medicine , ipilimumab , cancer , adverse effect , immunotherapy , melanoma , lung cancer , oncology , disease , clinical trial , kidney cancer , rheumatology , population , environmental health , cancer research

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom